Susanne Becker

Aptamer BC 007 - Efficient binder of spreading-crucial SARS-CoV-2 proteins

A. Haberland, H. Weisshoff, A. Dallmann, 2020, Heliyon.

In-Vivo Degradation of DNA-Based Therapeutic BC 007 in Humans

A. Haberland, H. Weisshoff, M. Grossmann, 2019, European Journal of Drug Metabolism and Pharmacokinetics.

KLKB1 and CLSTN2 are associated with HDL-mediated cholesterol efflux capacity in a genome-wide association study.

Hermann W. Haller, F. Kronenberg, W. Gronwald, 2023, Atherosclerosis.

A Three-Part, Randomised Study to Investigate the Safety, Tolerability, Pharmacokinetics and Mode of Action of BC 007, Neutraliser of Pathogenic Autoantibodies Against G-Protein Coupled Receptors in Healthy, Young and Elderly Subjects

G. Wallukat, A. Haberland, G. Golor, 2020, Clinical Drug Investigation.